Contract Manufacturing Industry News
-
Dr. Reddy’s Laboratories Ltd. And Merck Serono Announce Collaboration To Develop And Commercialize Biosimilars
6/6/2012
Dr. Reddy’s Laboratories Ltd. [NYSE:RDY] and Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today a partnership to co-develop a portfolio of biosimilar compounds in oncology, primarily focused on monoclonal antibodies (MAbs). The partnership covers co-development, manufacturing and commercialization of the compounds around the globe, with some specific country exceptions.
-
Declining R&D Budgets Drive Outsourcing Of Drug Discovery Functions
6/6/2012
Once an activity kept in-house at global pharmaceutical companies, the discovery of new compounds with a possible pharmacological effect is now increasingly handled by outside firms, according to Kalorama Information. The healthcare market research publisher said that companies are now routinely outsourcing a number of core functions including clinical trial management, manufacturing, and, increasingly, portions of the drug discovery process.
-
Anderson Packaging And Brecon Pharmaceuticals Realign Businesses To Form Full Service Global Pharmaceutical Packaging Company, AndersonBrecon
6/6/2012
Anderson Packaging, one of the fastest growing pharmaceutical, clinical and commercial contract packagers in the United States, and Brecon Pharmaceuticals, a leading supplier of pharmaceutical commercial packaging and clinical supply services in the UK, recently announced they are further aligning their businesses to become a global end-to-end pharmaceutical packaging company.
-
JHP Pharmaceuticals To Produce Clinical And Commercial Supply Of An Innovative Injectable
6/5/2012
JHP Pharmaceuticals, a provider of global contract manufacturing services for sterile products has entered into an agreement with an undisclosed pharmaceutical company to produce clinical and commercial supply of an innovative injectable used in the cardiovascular setting.
-
Company Recognized For Outstanding Contributions To The Pharmaceutical Sciences
5/30/2012
Morphotek®, Inc., a subsidiary of Eisai Inc., announced today that The American Association of Pharmaceutical Scientists (AAPS) has awarded its 2012 Excellence in Ligand Binding Assays Award to the Bioanalytical Development group from Morphotek for their abstract, “Development and Validation of a Pharmacokinetic Assay on the Gyrolab Platform for Use in Phase II/III Clinical Studies.” The award was presented at the AAPS 2012 National Biotechnology Conference held May 21-23 in San Diego.
-
Clean Room Environmental Best Practices For Medical Device And Pharmaceutical Manufacturers Are Focus Of Boston Seminar On June 6
5/30/2012
Sterile manufacturing environments at medical device and pharmaceutical companies require effective cleaning and disinfection programs to maintain aseptic conditions and prevent microbial contamination. To help, laboratory testing experts will present "Clean Room Environmental Best Practices," a special seminar in Boston on Wednesday, June 6, 2012.
-
Recipharm Secures Financing For Future Growth
5/23/2012
The company earmarks new EUR 90 million loan facility for further acquisition of niche CDMOs, investment in existing facilities and building long term partnerships with major pharmaceuticals companies.
-
Veeda Oncology Joins OmniComm’s CRO Preferred Program And Signs Agreement For First Study
5/23/2012
OmniComm Systems, Inc. (OTCBB: OMCM), one of the fastest growing companies in the Electronic Data Capture (EDC) marketplace, today announced that Veeda Clinical Research Inc., also known as Veeda Oncology®, has joined OmniComm's CRO Preferred Program, and as part of this program has signed an agreement to run their first study; a 27 month, phase I oncology trial.
-
SGS Acquires Vitrology Limited, Glasgow, UK And Enhances Offering For Biologic Therapeutics Testing
5/21/2012
SGS announced on May 18th the acquisition of Vitrology Limited based in Glasgow, UK. Vitrology is a biopharmaceutical Contract Testing Organisation and a dynamic force in the biosafety testing sector of the pharmaceutical industry.
-
Dr. Reddy’s Announces The Launch Of Over-The-Counter Lansoprazole Delayed-Release Capsules
5/21/2012
Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched over-the-counter (OTC) Lansoprazole delayed-release capsules in the US market on May 18, 2012 following Dr. Reddy’s ANDA approval by the United States Food & Drug Administration (USFDA).